Rectal Cancer: Multimodal Treatment Approach

Por Pramateftakis, Manousos-Georgios, Kanellos, Dimitrios, Tekkis, Paris P., Touroutoglou, Nikolaos, Kanellos, Ioannis
Publicado em 2012

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

Por Emmanouilides, Christos, Sfakiotaki, Georgia, Androulakis, Nikolaos, Kalbakis, Kostas, Christophylakis, Charalambos, Kalykaki, Antonia, Vamvakas, Lambros, Kotsakis, Athanasios, Agelaki, Sofia, Diamandidou, Eleni, Touroutoglou, Nikolaos, Chatzidakis, Adam, Georgoulias, Vassilis, Mavroudis, Dimitris, Souglakos, John
Publicado em 2007

KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study

Por Negru, Serban, Papadopoulou, Eirini, Apessos, Angela, Stanculeanu, Dana Lucia, Ciuleanu, Eliade, Volovat, Constantin, Croitoru, Adina, Kakolyris, Stylianos, Aravantinos, Gerasimos, Ziras, Nikolaos, Athanasiadis, Elias, Touroutoglou, Nikolaos, Pavlidis, Nikolaos, Kalofonos, Haralabos P, Nasioulas, George
Publicado em 2014